Clinical Trial Posts on Medivizor
Navigation Menu

Clinical Trial Posts on Medivizor

What anti-diabetic drugs are safe and effective in treating gestational diabetes?

Posted by on Oct 6, 2017 in Diabetes mellitus | 0 comments

In a nutshell This study investigated the safety and effectiveness of different drugs used to treat gestational diabetes. They found that metformin (Glucophage) is associated with fewer pregnancy complications than glyburide (Glynase), however it is less effective at managing blood sugar levels.  Some background Gestational diabetes...

Read More

Does dapagliflozin reduce the risk of cardiovascular complications in patients with type 2 diabetes?

Posted by on Sep 21, 2017 in Diabetes mellitus | 0 comments

In a nutshell This study investigated if dapagliflozin reduces the risk of developing cardiovascular complications in patients with type 2 diabetes. They found that dapagliflozin was associated with a lower risk of non-fatal heart attack and stroke compared to dipeptidyl peptidase-4 inhibitors (DPP-4i). Some background Cardiovascular (CV, heart...

Read More

Does bariatric surgery improve disease management in obese patients with type 2 diabetes?

Posted by on Aug 21, 2017 in Diabetes mellitus | 0 comments

In a nutshell This study investigated if combining bariatric surgery with medical therapy was more effective in treating type 2 diabetes in obese patients. The authors concluded that bariatric surgery in combination with medical therapy was more effective in improving diabetes symptoms in these patients. Some background Bariatric surgery is a...

Read More

Continuous glucose monitoring improves glycemic control in patients with type 1 diabetes

Posted by on Jul 15, 2017 in Diabetes mellitus | 0 comments

In a nutshell This study investigated the effect of continuous glucose monitoring (CGM) in managing blood sugar levels in patients with type 1 diabetes treated with multiple daily insulin injections. They found CGM resulted in a clinically meaningful improvement in glycemic (blood sugar) control. Some background Glycemic control is critical for...

Read More

Do You Understand Clinical Trials?

Do You Understand Clinical Trials?

Posted by on Mar 13, 2017 in Blog | 1 comment

In two previous posts, What Do You Think About Clinical Trials?  and What Do You Think? Medivizor’s Clinical Trials Perception Survey Results, we learned your perceptions of clinical trials.  As a follow-up, we have a short, very useful explainer video produced by the European Patients’ Academy (EUPATI) describing some of the key features of...

Read More

What Do You Think? Medivizor’s Clinical Trials Perception Survey Results

What Do You Think?  Medivizor’s Clinical Trials Perception Survey Results

Posted by on Nov 12, 2016 in Blog | 2 comments

In June, we published a post  called What Do You Think About Clinical Trials?  The post included the results of several surveys about perceptions of clinical trials including the results of  a study conducted by MaPS/Millward Brown Analytic and Memorial Sloan Kettering (MSKCC). Medivizor’s Clinical Trials Perception Survey Results In our post...

Read More

What Do You Think About Clinical Trials?

What Do You Think About Clinical Trials?

Posted by on Jun 23, 2016 in Blog | 7 comments

Please take this short survey on Clinical Trials…then read on! Surveys on Perceptions of Clinical Trials If you are like most people, you may not have a very positive opinion of clinical trials.  At least that is what a recent survey conducted by MaPS/Millward Brown Analytic and Memorial Sloan Kettering (MSKCC) suggests.  Only 40% of those...

Read More

Infliximab or biosimilar? A comparison between two similar drugs in patients with rheumatoid arthritis

Posted by on May 14, 2016 in Rheumatoid Arthritis | 0 comments

In a nutshell This study examined whether switching from infliximab (Remicade) to a similar drug had any influence on performance or side effects in patients with rheumatoid arthritis (RA). This study concluded that switching from infliximab to CT-P13 was safe and effective for patients with RA. Some background In rheumatoid arthritis (RA),...

Read More

A combination of afatinib and paclitaxel in EGFR-mutant non-small cell lung cancer

Posted by on Feb 7, 2016 in Lung cancer | 0 comments

In a nutshell This study aimed to determine the efficacy of a combination of the anticancer drugs afatinib (Gilotrif) and paclitaxel (Taxol) to treat non-small cell lung cancer (NSCLC), compared to chemotherapy alone. The study found that a combination of these drugs significantly improved progression free survival (PFS, time from treatment until...

Read More

The potential of Nivolumab in treating advanced NSCLC

Posted by on Jan 25, 2016 in Lung cancer | 0 comments

In a nutshell This study compared the efficacy of antitumor drugs nivolumab (Opdivo) and docetaxel (Taxotere) in the treatment of advanced non-small-cell lung cancer (NSCLC). The study concluded that nivolumab has better activity in advanced nonsquamous NSCLC which express the ligand PD-L1 and has a safer toxicity profile overall than docetaxel. Some...

Read More

Low vitamin D levels associated with infertility

Posted by on Jan 10, 2016 in Infertility | 0 comments

In a nutshell This study looked at vitamin D levels and pregnancy rates in patients undergoing in vitro fertilization (IVF). The study found that pregnancy rates were signficantly higher in the patients who had higher vitamin D levels. Some background Vitamin D is important for good health. The main source of vitamin D is from the action of...

Read More